A comparative study of bupropion and amitriptyline in depressed outpatients. 1983

J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh

A double-blind controlled trial comparing a standard antidepressant drug, amitriptyline, with a new compound, bupropion, was conducted at six centers. There was a placebo washout, after which patients were assigned in a randomized fashion to one of the two treatments. No significant difference was found in therapeutic response to the two drugs after 4 weeks of treatment. Anticholinergic and cardiovascular side effects were less common in the bupropion-treated patients.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011427 Propiophenones Propiophenone (ethyl phenyl ketone, structural formula C6H5COCH2CH3) and its derivatives. They are commonly used in perfumes and pharmaceuticals.
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh
January 1974, The American journal of psychiatry,
J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh
February 1974, Psychopharmacologia,
J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh
January 1982, Progress in neuro-psychopharmacology & biological psychiatry,
J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh
August 1970, The American journal of psychiatry,
J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh
September 1970, The American journal of psychiatry,
J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh
May 1983, The Journal of clinical psychiatry,
J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh
May 1983, The Journal of clinical psychiatry,
J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh
October 1982, The Journal of clinical psychiatry,
J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh
December 1973, The Journal of nervous and mental disease,
J Mendels, and M M Amin, and G Chouinard, and A J Cooper, and J E Miles, and R A Remick, and B Saxena, and S K Secunda, and A N Singh
May 1976, British medical journal,
Copied contents to your clipboard!